Is Micron a Good Stock to Buy Now?
Like most of its peers in the semiconductor industry, Micron…
Sell
43
PGNY Quote, Financials, Valuation and Earnings
Last price:
$21.39
Seasonality move
:
5.45%
Day range:
$21.06 - $21.75
52-week range:
$13.39 - $33.84
Dividend yield:
0%
P/E ratio:
37.54x
P/S ratio:
1.77x
P/B ratio:
4.33x
Volume:
1.4M
Avg. volume:
1.6M
1-year change:
-35.91%
Market cap:
$1.8B
Revenue:
$1.2B
EPS (TTM):
$0.57
Analysts' Opinion
-
Consensus RatingProgyny has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $26.75, Progyny has an estimated upside of 25% from its current price of $21.40.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $23.00 representing 100% downside risk from its current price of $21.40.
Fair Value
-
According to the consensus of 10 analysts, Progyny has 25% upside to fair value with a price target of $26.75 per share.
PGNY vs. S&P 500
-
Over the past 5 trading days, Progyny has underperformed the S&P 500 by -3.57% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Progyny does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Progyny has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Progyny reported revenues of $298.4M.
Earnings Growth
-
Progyny earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Progyny reported earnings per share of $0.12.
Enterprise value:
1.6B
EV / Invested capital:
--
Price / LTM sales:
1.77x
EV / EBIT:
23.72x
EV / Revenue:
1.37x
PEG ratio (5yr expected):
3.42x
EV / Free cash flow:
9.21x
Price / Operating cash flow:
11.93x
Enterprise value / EBITDA:
22.65x
Gross Profit (TTM):
$253.4M
Return On Assets:
7.73%
Net Income Margin (TTM):
4.66%
Return On Equity:
11.14%
Return On Invested Capital:
11.14%
Operating Margin:
5.29%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $786.9M | $1.1B | $1.2B | $269.9M | $298.4M | |
| Gross Profit | $167.3M | $238.8M | $253.4M | $56.9M | $63.4M | |
| Operating Income | $23.3M | $62.2M | $67.5M | $13.8M | $15.8M | |
| EBITDA | $24.9M | $64.5M | $70.6M | $14.4M | $16.7M | |
| Diluted EPS | $0.30 | $0.62 | $0.57 | $0.13 | $0.12 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $190.2M | $258.5M | $433.9M | $640.4M | $472.7M | |
| Total Assets | $253.9M | $358.1M | $543M | $756.6M | $607.1M | |
| Current Liabilities | $77.8M | $98.8M | $159.5M | $186M | $168.6M | |
| Total Liabilities | $87M | $106.2M | $166M | $203.2M | $185M | |
| Total Equity | $166.9M | $251.8M | $377M | $553.4M | $422.1M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $80.4M | $188.8M | $179.1M | $37.7M | $52.2M | |
| Cash From Investing | -$43.9M | -$200.5M | $195.8M | -$93.4M | $75M | |
| Cash From Financing | -$7.9M | -$11.1M | -$309.9M | -$5M | -$56.3M | |
| Free Cash Flow | $77.2M | $185.2M | $173.7M | $37M | $50.3M | |
PGNY
Sector
Market Cap
$1.8B
$35M
Price % of 52-Week High
63.24%
41.88%
Dividend Yield
0%
0%
Shareholder Yield
20.41%
-0.91%
1-Year Price Total Return
-35.91%
-43.29%
Beta (5-Year)
1.328
0.743
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$21.92
200-day SMA
Buy
Level
$20.57
Bollinger Bands (100)
Buy
Level
16.41 - 22.99
Chaikin Money Flow
Buy
Level
60M
20-day SMA
Sell
Level
$22.13
Relative Strength Index (RSI14)
Sell
Level
44.78
ADX Line
Sell
Level
16.2
Williams %R
Buy
Level
-83.7194
50-day SMA
Sell
Level
$22.07
MACD (12, 26)
Buy
Level
0.06
25-day Aroon Oscillator
Buy
Level
56
On Balance Volume
Neutral
Level
44.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (7.9949)
Buy
CA Score
(Annual)
Level (1.6424)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.9669)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
Stock Forecast FAQ
In the current month, PGNY has received 4 Buy ratings 6 Hold ratings, and 0 Sell ratings. The PGNY average analyst price target in the past 3 months is $26.75.
-
Where Will Progyny Stock Be In 1 Year?
According to analysts, the consensus estimate is that Progyny share price will rise to $26.75 per share over the next 12 months.
-
What Do Analysts Say About Progyny?
Analysts are divided on their view about Progyny share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Progyny is a Sell and believe this share price will drop from its current level to $23.00.
-
What Is Progyny's Price Target?
The price target for Progyny over the next 1-year time period is forecast to be $26.75 according to 10 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is PGNY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Progyny is a Hold. 6 of 10 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of PGNY?
You can purchase shares of Progyny via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Progyny shares.
-
What Is The Progyny Share Price Today?
Progyny was last trading at $21.39 per share. This represents the most recent stock quote for Progyny. Yesterday, Progyny closed at $21.40 per share.
-
How To Buy Progyny Stock Online?
In order to purchase Progyny stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Uber Finally on the Path to Consistent Profitability?
After posting massive losses quarter after quarter for years, Uber…
How High Will MSTY Go By 2030?
YieldMax’s MSTR Option Income Strategy ETF (MSTY) is a high-yield…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 31x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.5T
P/E Ratio: 36x
Alerts
Sell
25
BULZ alert for Apr 17
MicroSectors Solactive FANG & Innov 3X Levd ETN [BULZ] is down 10.95% over the past day.
Sell
50
IBKR alert for Apr 17
Interactive Brokers Group [IBKR] is down 8.97% over the past day.
Sell
39
FNGA alert for Apr 17
MicroSectors FANG+ Index 3X Leveraged ETN [FNGA] is down 9.37% over the past day.
